pharma Β· Melanoma Β· HIV Infections
Bristol Myers Squibb
Bristol-Myers Squibb
Bristol Myers Squibb trial registry β 41 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- 3401 Princeton Pike, Lawrence Township, NJ 08648, US
- Employees
- 38,146
- Programs
- 40
- Drugs
- 17
- Patents
- 25
Bristol Myers Squibb clinical trials
Registry index of 41 ClinicalTrials.gov studies linked to Bristol Myers Squibb programs β each row shows trial ID, program name, phase, status, and indication.
Bristol Myers Squibb trial registry β 41 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Bristol Myers Squibb.
-
AI455-110 β Phase 3
Clinical update -
Nivolumab β Phase 1
Clinical update -
Ipilimumab β Phase 3
Clinical update -
NKTR-214 β Phase 3
Clinical update -
BMS-641988 (AR#2) β Phase 1
Clinical update -
BMS-986165 β Phase 2
Clinical update -
ATV β Phase 3
Clinical update -
Daclatasvir β Phase 3
Clinical update
Trial registry
-
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β